Verastem Oncology submits NDA for ovarian cancer treatment
Verastem Oncology has concluded the rolling submission of a new drug application (NDA) to the US Food and Drug Administration…
Women's Health
-
-
FDA approves Iterum’s ORLYNVAH NDA for uUTI treatment
The US Food and Drug Administration (FDA) has approved Iterum Therapeutics' new drug application (NDA) for ORLYNVAH (sulopenem etzadroxil and…
-
Bayer applies for EU approval of menopause drug elinzanetant
Bayer has submitted a marketing authorisation application to the European Medicines Agency (EMA) for its menopause treatment elinzanetant. Bayer’s pill…
-
How personalised medicine can revolutionise contraception
Across the world, there are 1.9 billion women of reproductive age. According to a 2021 study from the World Health…
-
Mankind Pharma acquires Bharat Serums and Vaccines for $1.6bn
Mankind Pharma has announced a definitive agreement for the acquisition of a 100% stake in Bharat Serums and Vaccines (BSV)…
-
Bankrupt Mithra cashes in on remaining assets for $188.2m
A day after filing for bankruptcy, Mithra has sold its share in two of its daughter pharmaceutical companies along with…
-
Cervical cancer elimination in the UK is within sight with HPV vaccine
Cervical cancer is a serious condition but can be prevented with the human papillomavirus (HPV) vaccine. A recent study in…
-
Mithra sells position in Mayne Pharma to free up cash
Women’s health company Mithra has sold all its shares in Mayne Pharma for €12.8m ($13.7m), a week after the former…
-
Mithra sets out plan to rescue cash runway
Mithra Pharmaceuticals has revealed its next courses of action as the women’s health company looks to secure its cash flow…
-
Astellas seeks approval for Padcev-Keytruda combo therapy in Japan
Astellas Pharma has submitted a supplemental new drug application (sNDA) in Japan seeking approval for the combination of Padcev (enfortumab…
